Friday, May 1, 2026

Korean Researchers Achieve Breakthrough in High-Frequency Axion Detection

Researchers led by Dr. Yoon Seong-woo have enhanced axion detection sensitivity in high-mass regions, advancing dark matter studies.

LAUNCH IMMINENT: Kim Jong Un Prepares To Fire 9,300-Mile ICBM That Can NUKE Any City in the US

North Korea's recent engine tests at Dongchang-ri hint at a possible imminent launch of the new ICBM Hwasong-20, capable of striking the U.S.

LG Electronics says U.S. Tariff Refund Process Underway, Size and Timing Unclear

LG Electronics is processing tariff refunds from the U.S. while managing limited performance impacts through strategic measures.

Tag: 2026

Microgravity in Space May Revolutionize How Biopharmaceuticals Form and Function within the Body

Space's microgravity could transform biopharmaceuticals, enabling new treatments and technologies for diseases, emphasizing long-term research.

Discover the Breakthroughs of Korea’s ARPA-H Project: 5 Key Missions for Health Security and Innovation

The K-Health Future Promotion Team showcased interim results of the Korean ARPA-H project at Bio Korea 2026, focusing on innovative healthcare solutions.

Solum Healthcare Announces AI-Based Urine Test for Cancer at AACR Annual Meeting 2026

Solum Healthcare presented AI-driven non-invasive cancer detection using urine samples at AACR 2026, attracting global interest and discussions.

How Dong-A ST’s SC5024 and ADC Innovations Could Change the Game Cancer Pipeline

Dong-A ST showcased its innovative cancer pipeline at AACR 2026, featuring promising preclinical findings and advanced therapeutic strategies.

Penetrium Bioscience Announces Finalization of New Clinical Strategy for Targeted Cancer Therapies

Penetrium Bioscience reveals new clinical strategy to combat drug resistance in cancer therapies at AACR 2026, launching Phase 2 trials.

Nesuparib: The Revolutionary Dual-Inhibitor for Pancreatic Cancer – Can It Outperform Existing Treatments?

Nesuparib shows promise in inhibiting pancreatic cancer metastasis, offering hope for patients regardless of BRCA mutation status.

Lunit’s AI-based bile duct cancer study selected for rapid oral presentation at U.S. oncology conference

Lunit will present five research abstracts at ASCO 2026, showcasing the expanding role of AI biomarkers in cancer treatment.

Verismo unveils preclinical data on improved antitumor efficacy and safety of blood cancer CAR-T at AACR

HLB Innovation's SynKIR-310 shows improved antitumor activity and safety in preclinical trials, achieving 100% survival in mice.

GC Biopharma Presents Aggregation Study of Alyglo IVIG… A New Benchmark for Safe Immunotherapy

GC Biopharma USA will present findings on IVIG formulations, highlighting Alyglo's lower protein aggregation and improved stability at NHIA 2026.

Next-Gen Cancer Drug Nesuparib: How It Outperforms Olaparib in SCLC and Pancreatic Cancer

Onconic Therapeutics will present Nesuparib research at AACR 2026, showcasing its potential for various cancers and overcoming PARP inhibitor limitations.

Neurophet Unveils AI-Powered Alzheimer’s Treatment Software at ITEM 2026 in Japan

Neurophet showcases AI-driven brain disease tech at ITEM 2026 in Japan, partnering with Hokuyaku Takeyama to expand market reach.

How Hanmi’s Dual Inhibitor HM97662 is Revolutionizing Cancer Treatment: Key Insights from AACR 2026

Hanmi Pharmaceutical to present nine groundbreaking cancer research studies at AACR 2026, showcasing innovative therapies and AI-driven analytics.

GI-101A: Breakthrough Immuno-Oncology Drug Set for ASCO 2026 Presentation

GI Innovation's GI-101A will be presented at ASCO 2026, highlighting its clinical potential and significance in oncology.

Alpha Tau Medical’s Alpha DaRT: A New Hope for Pancreatic Cancer Patients – What You Need to Know

Alpha Tau Medical will present clinical results of its DaRT technology for pancreatic cancer at DDW 2026, marking a significant milestone.

Top News

- Our Sponsors Ad -

Follow us